albumin bound paclitaxel

DRUG6 trials

Sponsors

Massachusetts General Hospital, Sun Yat-sen University, Fudan University, Lee's Pharmaceutical Limited

Conditions

Advanced Urothelial CarcinomaEsophageal CancerGastric CancerGastric CanerPancreatic CystsTriple Negative Breast Cancer

Phase 1

A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.

Lee's Pharmaceutical LimitedEsophageal Cancer

Start: 2020-11-18End: 2023-07-15Target: 70Updated: 2022-05-04

A Study of Anti-PD-L1 Antibody ZKAB001 Combined With Albumin-bound Paclitaxel in Advanced Urothelial Carcinoma

Lee's Pharmaceutical LimitedAdvanced Urothelial Carcinoma

Start: 2020-09-10End: 2023-08-25Target: 20Updated: 2022-01-24

Phase 2

Albumin Bound Paclitaxel Plus S-1 as the First Line Chemotherapy in Advanced or Recurrent Gastric Cancer

CompletedNCT02229058

Sun Yat-sen UniversityGastric Cancer

Start: 2012-02-29End: 2017-02-28Updated: 2017-07-27

Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer

Sun Yat-sen UniversityGastric Caner

Start: 2010-11-30End: 2014-12-31Target: 37Updated: 2014-08-29

Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients

Active, not recruitingNCT04418154

Fudan UniversityTriple Negative Breast Cancer

Start: 2020-06-09End: 2025-12-31Updated: 2024-05-21

Unknown Phase

Endoscopic Abraxane Injection Into Pancreatic Cysts

TerminatedNCT01698710

Massachusetts General HospitalPancreatic Cysts

Start: 2012-11-30End: 2014-09-30Updated: 2017-06-21

Related Papers

Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma

The Oncologist2024-10-173 citations

Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study.

2024-06-2811 citations

Abstract PO2-03-05: Neoadjuvant anthracycline followed by Toripalimab combined with nab-paclitaxel in patients with stage IIA-IIIC triple negative breast cancer (NeoTENNIS): efficacy and safety results of a phase II study

Cancer Research2024-05-02

Abstract PO2-13-04: Single cell characterization of senescent CD8+ T cell promotes immunotherapy resistance in early-stage triple-negative breast cancer

Cancer Research2024-05-02

Abstract PO1-15-09: Vitamin A Metabolism Induces Ferroptosis to Enhance Immune Therapy Efficacy in HR+/HER2- Breast Cancer

Cancer Research2024-05-02

Comparing a PD-L1 inhibitor plus chemotherapy to chemotherapy alone in neoadjuvant therapy for locally advanced ESCC: a randomized Phase II clinical trial : A randomized clinical trial of neoadjuvant therapy for ESCC.

2023-03-0832 citations

Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma.

Journal of Clinical Oncology2022-06-011 citations

Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design.

2021-11-1023 citations

Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel as first-line chemotherapy for patients with metastatic gastric cancer.

Journal of Clinical Oncology2016-05-20